# HypnoVR

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hypnovr

- Industry: Software
- Headquarters: Strasbourg, France
- Website: www.hypnovr.io
- Total disclosed funding: $5.1M
- Latest round: Series A (Dec 6, 2021)
- Investors on record: 5

## About

HypnoVR is a pioneering company focused on delivering digital therapies that harness virtual reality and hypnosis to alleviate pain and anxiety in medical settings.Founded in 2016 in Strasbourg, France, HypnoVR specializes in innovative digital therapeutic solutions that merge medical hypnosis with high-definition 3D virtual reality and therapeutic music. The company has completed a total of 3 deals, with its most recent funding round being a Series A in December 2021, where it raised EUR 4.007 mn led by Banque des Territoires and other investors including Akiles and Capital Grand Est. The current CEO, Nicolas Schaettel, is among the founders, which also include Belal Shohayeb and Denis Graff.HypnoVR specializes in digital therapies designed to reduce pain and anxiety through a unique multisensory immersive experience. The core product offerings include a comprehensive digital therapeutic solution that integrates medical hypnosis with high-definition 3D virtual reality environments and therapeutic music. This clinically validated approach provides a non-pharmacological alternative for managing pain, stress, and anxiety across various medical settings such as anesthesia, surgery, dental care, imaging, oncology, and pediatrics. HypnoVR's solutions are deployed in over 500 healthcare institutions globally, with a focus on enhancing patient care experiences.HypnoVR generates revenue primarily through partnerships and subscriptions with healthcare institutions using its digital therapeutic products. The pricing structure is tailored for healthcare facilities, promoting seamless integration of HypnoVR's offerings. Clients subscribe to the platform to access various products, including HypnoVR, HypnoVR Biofeedback, and HypnoVR Dental. Revenue transactions are executed through direct agreements with hospitals and clinics, ensuring consistent income from the recurring subscription model and ongoing support services.In December 2021, HypnoVR raised EUR 4 mn in Series A funding to enhance the availability of its hypnosis solutions in health establishments both in France and abroad while also strengthening its teams. The company plans to expand into new geographic regions and markets, focusing on accelerating its product offerings in international healthcare sectors. The recent funding will be crucial in supporting these initiatives, allowing HypnoVR to broaden its reach and enhance its technological capabilities.

## Funding rounds

- Series A, Dec 6, 2021, $4.5M — Capital Grand Est, Seido Capital, Banque des Territoires, Akiles
- Seed, Jun 25, 2018, $0.6M — Vivalto Partners

## Investors

- Vivalto Partners (https://capitalatlas.ai/funds/vivalto-partners) — Seed
- Capital Grand Est (https://capitalatlas.ai/funds/capital-grand-est) — Series A
- Seido Capital (https://capitalatlas.ai/funds/seido-capital) — Series A
- Banque des Territoires — Series A
- Akiles (https://capitalatlas.ai/funds/akiles) — Series A